Liquid Biopsy to Determine Patient Response to Immune Checkpoint Blockade

Cancer News

Article from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes: 

Determining which cancers may be responsive to immune checkpoint inhibitors is problematic. These investigators discovered that liquid biopsy may provide an answer.

Go to full article published by The ASCO Post.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

Back to Cancer Insights